Do print ads touting a prescription drug as “new” or “#1 prescribed” impact consumer perceptions of a product? That’s the question FDA aims to answer in its latest study of direct-to-consumer Rx drug advertising.
The study, “Market Claims in Direct-to-Consumer Prescription Drug Print Ads,” will assess the impact of market claims on perceptions with...